Clinical Trials in San Diego

Showing 3541-3560 of 7,028 trials

A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

NCT04411628

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate it. Participation could last about 8 weeks and may include up to 15 visits in the hospital or the home.

COVID-19

Eli Lilly and Company26 participantsStarted May 2020

Los Angeles, California, United States • San Diego, California, United States • Atlanta, Georgia, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

NCT02139644

The primary objective of this study was to evaluate the efficacy of fluticasone propionate multidose dry powder inhaler (Fp MDPI) and fluticasone propionate/salmeterol xinafoate multidose dry powder inhaler (FS MDPI) when administered over 12 weeks in patients 12 years of age and older with persistent asthma. Study drug and placebo was supplied in Teva multidose dry powder inhaler (MDPI) devices and provided for participants to use at home. Participants performed spirometry at every visit. Each participant was given a diary at each visit for use until the next visit. Rescue medication (albuterol/salbutamol) was dispensed at each visit, if needed, as determined by the investigational center personnel.

Asthma

Teva Branded Pharmaceutical Products R&D, Inc.787 participantsStarted Jun 2014

Birmingham, Alabama, United States • Glendale, Arizona, United States • Cypress, California, United States +137 more locations

A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

Find Trials by Condition in San Diego

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

Addressing Involuntary Movements in Tardive Dyskinesia

Aim to Reduce Movements in Tardive Dyskinesia

A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)

Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLC